The British Journal of Clinical Pharmacy has published the report about the regulatory approval status and sales volumes of systemic antibiotics marketed in India.
A research conducted by Queen Mary University of London and Newcastle University revealed that multinational companies produced and sold unregulated antibiotics in India on a large scale.
The Results are alarming:-
Of 118 systemic antibiotic FDC formulations marketed in India,
- 43(36%) were approved
- 75 (64%) had no record of regulatory approval;
- 5(4%) formulations were approved in the UK and/or US.
For further details read here